Making Sense of MS Research

Summaries of independent,
high-quality research about multiple sclerosis treatments

Interferons for Relapsing Remitting MS

Does this apply to me?

When deciding if this information applies to you it’s helpful to think about how similar you are to the people that were included in the studies.

What we know about the people included in the Interferons studies:

  • They had relapsing remitting MS (for between 1 to 30 years)
  • They were aged between 18 to 57 years
  • They included people with mild to moderate disability levels

If I am similar to the people in the studies, can I expect the same results?

It is important to remember that studies deal with averages and statistics. Even if you are similar to the people in the studies, we can’t know for sure that you will respond in the same way.

What we can say, is that, on average, less people who take interferons will experience a relapse in the first two years, compared to people who do not take interferons.

If you have other kinds of MS, please see our other summaries on the effects of Interferons in people with clinically isolated syndrome (CIS) (coming soon), primary progressive MS (PPMS) and secondary progressive MS (SPMS).